META-ANALYSIS OF CAUSES OF DEATH IN PATIENTS RECEIVING DIRECT ORAL ANTICOAGULANTS OR WARFARIN FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION

被引：0
|
作者：
Gomez Outes, A. [1 ]
Lagunar, J. [2 ]
Terleira, A., I [2 ,3 ]
Calvo, G. [4 ]
Suarez, M. L. [1 ]
Vargas, E. [2 ,3 ]
机构：
[1] Spanish Agcy Med & Med Devices AEMPS, Madrid, Spain
[2] Hosp Clin San Carlos, Madrid, Spain
[3] Univ Complutense, Madrid, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2016年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CP22
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A SUBGROUP META-ANALYSIS IN EUROPEAN PATIENTS
    Gomez-Outes, A.
    Suarez-Gea, M. L.
    Terleira-Fernandez, A. I.
    Vargas-Castrillon, E.
    Calvo-Rojas, G.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E10 - E10
  • [2] NEW ORAL ANTICOAGULANTS VERSUS WARFARIN ON PRIMARY AND SECONDARY PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
    Gomez-Outes, A.
    Terleira-Fernandez, A.
    Suarez-Gea, M. L.
    Vargas-Castrillon, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 32 - 32
  • [3] A NETWORK META-ANALYSIS EVALUATING THE CUMULATIVE HAZARD RATE OF STROKE OR SYSTEMIC EMBOLISM FOR NEW ORAL ANTICOAGULANTS IN STROKE PREVENTION FOR ATRIAL FIBRILLATION PATIENTS
    Cope, S.
    Keen, A.
    Bergrath, E.
    Chen, M.
    VALUE IN HEALTH, 2014, 17 (03) : A105 - A105
  • [4] Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
    Thitima Kongnakorn
    Tereza Lanitis
    Lieven Annemans
    Vincent Thijs
    Marnix Goethals
    Sophie Marbaix
    Jean-Claude Wautrecht
    Clinical Drug Investigation, 2015, 35 : 109 - 119
  • [5] Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
    Kongnakorn, Thitima
    Lanitis, Tereza
    Annemans, Lieven
    Thijs, Vincent
    Goethals, Marnix
    Marbaix, Sophie
    Wautrecht, Jean-Claude
    CLINICAL DRUG INVESTIGATION, 2015, 35 (02) : 109 - 119
  • [6] Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation and Hypertension: A Meta-Analysis
    Zheng, Yayuan
    Liu, Yuyu
    Bi, Jihong
    Lai, Weiguang
    Lin, Chunyu
    Zhu, Jianhong
    Yao, Weimin
    Chen, Qiusheng
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (05) : 477 - 485
  • [7] Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation and Hypertension: A Meta-Analysis
    Yayuan Zheng
    Yuyu Liu
    Jihong Bi
    Weiguang Lai
    Chunyu Lin
    Jianhong Zhu
    Weimin Yao
    Qiusheng Chen
    American Journal of Cardiovascular Drugs, 2019, 19 : 477 - 485
  • [8] Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis
    Andersen, L. V.
    Vestergaard, P.
    Deichgraeber, P.
    Lindholt, J. S.
    Mortensen, L. S.
    Frost, L.
    HEART, 2008, 94 (12) : 1607 - 1613
  • [9] DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN/VITAMIN K ANTAGONISTS FOR STROKE PREVENTION IN FRAIL PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Jain, Akhil
    Shenwai, Priya
    Lakshmanan, Ankita
    Mohammad, Aamer
    Merugu, Neha Bhavyasri
    Gaddam, Neelima
    Guzman, Frailyn Nunez
    Itare, Vikram
    Raina, Jilmil
    Desai, Rupak
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 46 - 46
  • [10] Are direct oral anticoagulants effective in reducing systemic embolism in patients with atrial fibrillation? A systematic review and meta-analysis of the literature
    Mumoli, Nicola
    Cei, Marco
    Vitale, Jose
    Fontanella, Andrea
    Dentali, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 180 : 192 - 195
12345